A novel pegylated bispecific antibody-drug conjugate (P-BsADC) targeting Her2+cancers with improved efficacy and therapeutic window

被引：0
|
作者：
Wen, Yu
Yin, Shuqiang
Lyu, Weidong
Lei, Yang
Zhuo, Qiudong
Wu, Zibin
Sun, Bin
Tan, Shuangyu
Jiang, Lidong
Zhang, Teng
Gao, Bo
Xu, Rui
Li, Yong
Zheng, Liling
Liu, Shumin
Wu, David
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 07期
关键词：
D O I：
10.1158/1538-7445.AM2023-4000
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4000
引用
收藏
页数：2
相关论文
共 50 条
  • [1] A novel pegylated bispecific antibody-drug conjugate (P-BsADC) JY207b targeting cancers co-expressing PD-L1 and CD47
    Wen, Yu
    Liu, Shumin
    Lyu, Weidong
    Lei, Yang
    Tan, Shuangyu
    Wu, Zibin
    Yin, Shuqiang
    Zhuo, Qiudong
    Wu, Dechun
    CANCER RESEARCH, 2024, 84 (06)
  • [2] A novel pegylated biparatopic antibody-drug conjugate (pb-adc) targeting cancers with low HER2+ expression
    Liu, Shumin
    Yin, Shuqiang
    Lyu, Weidong
    Lei, Yang
    Zhuo, Qiudong
    Wu, Zibin
    Tan, Shuangyu
    Zheng, Liling
    Wen, Yu
    Wu, David
    CANCER RESEARCH, 2022, 82 (12)
  • [3] A novel bispecific antibody drug conjugate targeting HER2 and HER3 with potent therapeutic efficacy against breast cancer
    Zong, Hui-fang
    Li, Xi
    Han, Lei
    Wang, Lei
    Liu, Jun-jun
    Yue, Ya-li
    Chen, Jie
    Ke, Yong
    Jiang, Hua
    Xie, Yue-qing
    Zhang, Bao-hong
    Zhu, Jian-wei
    ACTA PHARMACOLOGICA SINICA, 2024, 45 (08) : 1727 - 1739
  • [4] BCG022, a novel HER3 x MET bispecific antibody-drug conjugate (bsADC), demonstrates promising anti-tumor efficacy
    Li, Zhuolin
    Shang, Chengzhang
    Han, Zhenyan
    An, Gao
    Guo, Chaoshe
    An, W. Frank
    Yang, Yi
    CANCER RESEARCH, 2024, 84 (06)
  • [5] BCG022: A novel bispecific antibody-drug conjugate targeting HER3 and MET
    Li, Zhuolin
    Shang, Chengzhang
    Guan, Xuewa
    Han, Zhenyan
    An, Gao
    Zhang, Ellen
    Lin, Qingcong
    Yang, Yi
    CANCER RESEARCH, 2023, 83 (08)
  • [6] A novel pegylated bispecific antibody-drug conjugate (P-BsADCpb-adc) targeting cancers co-expressing PD-L1 and CD47
    Liu, Shumin
    Lyu, Weidong
    Yin, Shuqiang
    Lei, Yang
    Zhuo, Qiudong
    Zheng, Liling
    Sun, Bin
    Tan, Shuangyu
    Jiang, Lidong
    Zhang, Teng
    Gao, Bo
    Xu, Rui
    Huang, Dechang
    Li, Yong
    Wu, Zibin
    Wu, David
    Wen, Yvonne Yu
    CANCER RESEARCH, 2023, 83 (07)
  • [7] DB-1310, a novel Her3 targeting antibody-drug conjugate, exhibits therapeutic efficacy for solid tumors
    Li, Xi
    Yao, Jun
    Qu, Chen
    Lan, Luo
    Li, Bing
    Zhang, Yu
    Shi, Rong
    Hua, Haiqing
    Qiu, Yang
    CANCER RESEARCH, 2023, 83 (07)
  • [8] Efficient Payload Delivery by a Bispecific Antibody-Drug Conjugate Targeting HER2 and CD63
    de Goeij, Bart E. C. G.
    Vink, Tom
    ten Napel, Hendrik
    Breij, Esther C. W.
    Satijn, David
    Wubbolts, Richard
    Miao, David
    Parren, Paul W. H. I.
    MOLECULAR CANCER THERAPEUTICS, 2016, 15 (11) : 2688 - 2697
  • [9] Generation of a Novel SORT1xHER2 Bispecific Antibody-Drug Conjugate Targeting HER2-Low-Expression Tumor
    Zhuang, Weiliang
    Zhang, Wei
    Wang, Lei
    Xie, Liping
    Feng, Jun
    Zhang, Baohong
    Hu, Youjia
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (22)
  • [10] Engineering a HER2-specific antibody-drug conjugate to increase lysosomal delivery and therapeutic efficacy
    Kang, Jeffrey C.
    Sun, Wei
    Khare, Priyanka
    Karimi, Mostafa
    Wang, Xiaoli
    Shen, Yang
    Ober, Raimund J.
    Ward, E. Sally
    NATURE BIOTECHNOLOGY, 2019, 37 (05) : 523 - +
12345